PTAB: Inadvertent Mistake in Analysis of Experimental Data that Substantially Impacts Proceeding Cannot be Corrected

Oct 6, 2020

Reading Time : 2 min

Petitioner Sweegen, Inc. filed a petition for post grant review (PGR) of a patent covering a method of making a certain chemical compound. Petitioner argued that the claims were anticipated by an example in a prior art reference. To support its anticipation argument, Petitioner commissioned a bioanalytical chemistry laboratory to replicate that example. Based on the testing results, Petitioner submitted two declarations and argued that performing the example in that reference would have necessarily produced a certain product. Almost a month after Petitioner filed the exhibits, one of the laboratory’s employees discovered that the test results “inadvertently linked the tables to the incorrect data cells.” The correct results showed that more than twice the reported amount of the compound was actually produced in the reaction. Petitioner filed a motion to correct the error. Patent Owner opposed the motion and contended that the “proposed changes [would] have a substantial impact on the[] proceedings.”

The board acknowledged that clerical mistakes may be corrected as long as they do not sacrifice the notice function of a petition. The board considers several non-exclusive factors to determine whether to allow correction. Here, the board first found that the nature of the error was “substantial because Petitioner [sought] to change the data in three tables.” Even if the errors in the original report resulted from a clerical error, the proposed changes were “not mere clerical errors that may be corrected under Rule 104(c).” This factor weighed strongly in Patent Owner’s favor. Second, the board found that although there was some delay between discovery of the error and bringing it to the board’s attention, the delay was not unreasonable. Thus this second factor was neutral. Third, the board found that since the proposed changes were substantive, it would be prejudicial to force the Patent Owner to alter its arguments to account for the corrected data. Finally, the board found that the corrections would have a significant impact on the proceeding because they would “improv[e] Petitioner’s anticipation argument.” The third and fourth factors weighed heavily in Patent Owner’s favor. As a whole, the factors weighed in favor of Patent Owner and the board denied Petitioner’s motion.

Practice Tip: Petitioners should ensure that all supporting documents are correct before submitting the petition. A petitioner may not be permitted to correct clerical and typographical errors in its petition and supporting documents if the changes would require substantive alterations to the petitioner’s evidence or argument.

Sweegen, Inc. v. Purcircle SDN BDH, PGR2020-00070, Paper 9 (PTAB Sept. 22, 2020).

Share This Insight

Previous Entries

IP Newsflash

June 6, 2025

In a precedential opinion, the Federal Circuit definitively held that the Patent Trial and Appeal Board has jurisdiction over IPRs that concern expired patents.

...

Read More

IP Newsflash

June 6, 2025

In a patent infringement litigation in the U.S. District Court for the Eastern District of Texas, Judge Rodney Gilstrap denied a joint motion to stay the litigation pending resolution of inter partes review when it was uncertain that all defendants would be bound by the statutory estoppel provision of 35 U.S.C. § 315(e).

...

Read More

IP Newsflash

May 30, 2025

A district court recently dismissed a patent infringement complaint for improper venue under 28 U.S.C. § 1400(b), finding that the storage and distribution of products from an Amazon warehouse was not sufficient to establish that warehouse as a regular and established place of business in the district.

...

Read More

IP Newsflash

May 27, 2025

The Federal Circuit affirmed a District of Delaware finding of non-infringement in an ANDA litigation due to the patentee’s clear and unmistakable disavowal of claim scope during prosecution. Specifically, the court held that statements made during prosecution of a parent application before the asserted claims were allowed amounted to a prosecution disclaimer that extended to subsequent patents in the family. In reaching this conclusion, the court rejected an attempt by the patentee to resurrect the claim scope through a unilateral, self-serving statement made in later applications in the family.

...

Read More

IP Newsflash

May 13, 2025

The Federal Circuit recently affirmed a district court’s holding that patent term extension (PTE) for a reissued patent was properly based on the issue date of the original patent and not that of the reissued patent. The Federal Circuit concluded that, where both the original and reissued patents claimed a drug product under regulatory review, using the issue date of the original patent to calculate PTE comports with both the purpose of the Hatch-Waxman Act and the related statutory context.

...

Read More

IP Newsflash

May 12, 2025

The Patent Trial and Appeal Board recently declined to institute a petition for IPR that was filed on the same day that the petitioner filed another petition challenging the same claims of the same patent. The board was not persuaded by petitioner’s arguments that a second petition was needed due to alleged claim construction issues or the number, length or scope differences of the challenged claims.

...

Read More

IP Newsflash

May 9, 2025

The USPTO Director vacated the board’s decision to institute inter partes review based on an erroneous application of the Fintiv factors. Specifically, the Director found that the board placed too much emphasis on Petitioner’s Sotera stipulation, and not enough emphasis on the investment in the parallel litigation. Weighing the factors as a whole, the Director determined that institution should be denied.

...

Read More

IP Newsflash

May 9, 2025

In an institution decision following the USPTO’s withdrawal of its Fintiv Memo, the board addressed discretionary denial of an IPR under Fintiv in view of a parallel ITC investigation. The board noted it would not consider the now-rescinded June 2022 memo from then-director Vidal which instructed that the PTAB would not deny institution of an IPR or PGR under Fintiv when the request is based on a parallel ITC investigation. The board conducted a Fintiv analysis in view of the ITC investigation, but ultimately determined that discretionary denial was not warranted in this particular situation.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.